1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Novel Agents: Making the Benefit Last in CLL – Medscape

December 18, 2013Monoclonal Anti-CD20 Antibodiesadmin

Medscape

Novel Agents: Making the Benefit Last in CLL
Medscape
Bruce D. Cheson, MD: Hello. I am Bruce Cheson, Deputy Chief of Hematology-Oncology, and Head of Hematology at Georgetown University Hospital at the Lombardi Comprehensive Cancer Center in Washington, DC. Welcome to this edition of Medscape ...

Post navigation

← Opt for Life campaign welcome organ donation reforms – thejournal.ie Copywriter Mita Diran Dies Of Heart Failure After Working 30 Hours Straight … – Headlines & Global News →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos